Biological
ABO1108 clinical trials
Also written ABO1108.
- studies test it
- 3
- open now
- 1
- in phase 3
- 1
- first study started
- 2025
Keep track of what changes. Save the ABO1108 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Suzhou Abogen Biosciences Co., Ltd. (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ABO1108 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or AboveRecruitingPhase 3Suzhou Abogen Biosciences Co., Ltd.NCT07817108Written as ABO1108
- Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or AboveActive, not recruitingPhase 2Suzhou Abogen Biosciences Co., Ltd.NCT07285278Written as ABO1108
- Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or AboveActive, not recruitingPhase 1Suzhou Abogen Biosciences Co., Ltd.NCT07285265Written as ABO1108